Pediatric Surgery for Central Venous Access
- Author: Floriano Putigna, DO, FAAEM; Chief Editor: Marleta Reynolds, MD more...
Background
The need for vascular access in the pediatric patient is frequent; however, placement of a peripheral line may not be feasible or appropriate. The options available to clinicians have increased over the years; central venous access devices (CVADs) are now used with greater frequency. This article discusses the various options available for central venous access and their advantages, disadvantages, and complications.
History of the Procedure
The history of cannulation of a central venous structure can be traced back to 1929, when Forssmann described advancing a plastic tube near the heart by puncturing his own arm.[1] In the 1950s, Aubaniac used the subclavian vein to insert a central venous catheter (CVC).[2] Since then, several more access routes of have been described. New equipment makes the use of CVADs increasingly safer and more common.
Problem
CVADs come in many different sizes and brands that allow the clinician to choose the best device for their patient. However, the small sizes of the devices and of pediatric patients can complicate CVAD procedures in children.
CVADs include peripheral intravenous central catheters (PICCs), CVCs, implantable access ports (IAPs), umbilical artery catheters (UACs), and umbilical vein catheters (UVCs). These devices can be placed in numerous sites, including the internal jugular vein (IJV), subclavian vein, femoral vein, peripheral veins leading to central access, and other surgical access sites.
Epidemiology
Frequency
Approximately 5 million CVC insertions are performed every year in the United States. This rate accounts for 15 million CVC days each year in the intensive care units (ICUs). The use of CVCs in the ICU is similar in adult and pediatric patients.
Presentation
The range of clinical presentations in patients receiving a CVC is broad.[3] They may be hypovolemic or in shock with severely vasoconstricted peripheral sites. They may be an oncology patient or may have bacteremia and require continuous intravenous (IV) access for prolonged periods, thereby requiring an accessible IV site.
Patients with bloodstream infections (BSIs) or catheter-related infections may have redness, exudate, swelling, or increased pain at the insertion site. They may only have an elevated temperature or abnormal vital signs if immunocompromised.
Indications
The indications for central lines in children parallel the indications for adults. Central venous access devices (CVADs) are used to deliver larger volumes of irritating solutions, such as antibiotics, blood products, parenteral nutrition media, and sclerosing chemotherapeutic agents. If patients need prolonged intravenous (IV) access, a CVAD is preferred to a peripheral IV line. Central access is also indicated when peripheral access cannot be achieved; however, in an emergency situation, an intraosseous needle is probably the primary choice according to Pediatric Advanced Life Support (PALS) guidelines.
Peripheral intravenous central catheters
Peripheral intravenous central catheters (PICC) lines have been used with great success in neonatal intensive care units (NICUs) and are considered a mainstay of vascular access in this setting. Although the lines are placed peripherally, usually in the antecubital or superficial saphenous vein, the distal tip remains in a large central vein. PICC lines are indicated in children who require intermediate-term IV access for prolonged home or hospital therapy, such as those with human immunodeficiency virus (HIV) infection, cystic fibrosis,[4]osteomyelitis, meningitis, or cancer.
The success of introducing the PICC line is greater if attempts at inserting noncentral peripheral lines are limited. Therefore, PICC placement should be attempted as soon as the need for intermediate-term access is apparent.
Central venous catheters
CVCs are inserted at femoral, subclavian, and internal jugular vein (IJV) sites. These devices are preferred in children who have no peripheral access and in those who require long-term IV access. The subclavian route has been the preferred route for many years and allows the patient greatest mobility. The femoral line should be the primary route in children who are not sedated, somewhat combative, or receiving cardiopulmonary resuscitation (CPR). A femoral site is the best location for a patient receiving CPR because it does not interfere with chest compressions or defibrillation.
Implantable access ports
Implantable access ports (IAPs), such as Mediport and Port-A-Cath, are to be used when vascular access is prolonged and when the following must be minimized: risk of infection, daily activities, alterations in body image, and dressing changes.[5] IAP devices must be surgically implanted, usually in the operating room.
An expertise-based randomized trial compared the insertion techniques of venous cutdown approach with puncture of subclavian vein for implantation of totally implantable access ports (TIAP). The results found that while both techniques can be safe and effective, the percutaneous approach took more time, required a higher dose of radiation, and is associated with risk of pneumothorax.[6]
Umbilical artery catheters and umbilical vein catheters
Accessing the umbilical system is useful in the first few days of life. The umbilical vein can be used for access during the first 5-7 days but is rarely used beyond 7 days.
Both and umbilical artery catheters (UACs) and umbilical vein catheters (UVCs) can be used: UAC is used for blood pressure monitoring, and UVC is used for central venous pressure monitoring.
These vascular access sites are recommended in a neonatal emergency or if prolonged medication administration and blood draws are needed. Surgical venous access sites, such as the azygous, hemiazygous, inferior epigastric, or lumbar veins, should be considered only if all other options have failed and only if experienced clinicians have deemed it necessary to access these vessels. An interventional radiologist can be of assistance in minimizing the procedures (eg, thoracotomy, cut down) required to access these sites.
Relevant Anatomy
After the decision has been made to place a central venous access device (CVAD), a clear understanding of the anatomy is needed for each of the different approaches. The 4 main approaches to central venous access discussed here include the internal jugular, subclavian, femoral, and peripheral intravenous central catheter (PICC) methods.
Internal jugular approach
The internal jugular vein (IJV) parallels and is lateral to the internal carotid artery in the neck.
Internal jugular vein, anterior approach.
Internal jugular vein, central approach.
Internal jugular vein, posterior approach. It lies in the carotid sheath, which includes the carotid artery and vagus nerve. The IJV is a branch of the brachiocephalic vein.
Subclavian approach
The subclavian artery lies posterior and somewhat superior to the brachiocephalic vein. These 2 vessels are separated by the anterior scalene muscles. The subclavian vein begins distal to the branch point of the IJV. It crosses under the clavicle at the medial to proximal third of the clavicle. The subclavian artery is located deep and slightly superior to the vein.
In children, the subclavian vein is located more cephalic than it is in adults, meaning that it dives under the clavicle closer to the medial third.
Deep to the vessels lies the first rib, which is just superficial to the pleura and lung.
Femoral approach
The femoral vein is a branch of the external iliac vein.
Femoral vein approach. Remember the mnemonic NAVEL for nerve, artery, vein, empty space, and lymphatics. It crosses deep to the medial third of the inguinal ligament. A common mnemonic for the anatomy of the femoral vessels from lateral to medial is NAVEL: nerve, artery, vein, empty space, and lymphatics.
Peripheral intravenous central catheter approach
The relevant anatomy for inserting a PICC line include the superficial veins to be used. These are primarily located in the arms (cephalic and basilica veins), scalp (superficial temporal vein), or neck (external jugular vein).
The umbilical system consists of 2 arteries and 1 vein.
Umbilical vein, cannulation in the newborn. The vein is usually at the 12-o'clock position and is larger with thinned walls. The arteries are located inferiorly with thicker walls. Occasionally, a persistent urachus may be encountered and mistaken for the vein. However, a return of urine quickly reveals the error.
The vein travels to the inferior vena cava or it could turn to the portal system. The umbilical artery turns inferiorly then continues to the pelvis, where it meets the internal iliac artery continuing cephalad to the bifurcation of the aorta.
Contraindications
Contraindications for inserting a central venous catheter (CVC) include an infection or burn over the desired insertion site, a known venous thrombosis of the vessel, an uncorrected coagulopathy, an obstruction of the vein by a tumor or mass, an abnormal vessels, an ability to achieve the same objectives with a peripheral line, and a lack of consent in a nonemergency setting.
A relative contraindication is bacterial septicemia because cultures are generally recommended to be sterile for 36-48 hours prior to CVC insertion.
Forssmann W. Die Sondierung rechten Herzens. Klin Wschr. 1929;8:2080.
Aubaniac R. [Subclavian intravenous injection; advantages and technic]. Presse Med. Oct 25 1952;60(68):1456. [Medline].
Lomonte C, Basile C. [Management of central venous catheter: prevention of thrombosis and bacteremia.]. G Ital Nefrol. Jan-Feb 2009;26(1):73-80. [Medline].
Mogayzel PJ Jr, Pierce E, Mills J, et al. Accuracy of tobramycin levels obtained from central venous access devices in patients with cystic fibrosis is technique dependent. Pediatr Nurs. Nov-Dec 2008;34(6):464-8; quiz 468-9. [Medline].
Soucy P. Experiences with the use of the Port-a-Cath in children. J Pediatr Surg. Aug 1987;22(8):767-9. [Medline].
Knebel P, Lopez-Benitez R, Fischer L, et al. Insertion of Totally Implantable Venous Access Devices: An Expertise-Based, Randomized, Controlled Trial (NCT00600444). Ann Surg. Jun 2011;253(6):1111-7. [Medline].
Skippen P, Kissoon N. Ultrasound guidance for central vascular access in the pediatric emergency department. Pediatr Emerg Care. Mar 2007;23(3):203-7. [Medline].
[Best Evidence] Leung J, Duffy M, Finckh A. Real-time ultrasonographically-guided internal jugular vein catheterization in the emergency department increases success rates and reduces complications: a randomized, prospective study. Ann Emerg Med. Nov 2006;48(5):540-7. [Medline].
Verghese ST, McGill WA, Patel RI, et al. Ultrasound-guided internal jugular venous cannulation in infants: a prospective comparison with the traditional palpation method. Anesthesiology. Jul 1999;91(1):71-7. [Medline].
Casado-Flores J, Barja J, Martino R. Complications of central venous catheterization in critically ill children. Pediatric Critical Care Med. 2001;2(1):57-62. [Medline].
Goede MR, Coopersmith CM. Catheter-related bloodstream infection. Surg Clin North Am. Apr 2009;89(2):463-74. [Medline].
Henrickson KJ, Axtell RA, Hoover SM, et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial. J Clin Oncol. Mar 2000;18(6):1269-78. [Medline].
Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr. Dec 1998;133(6):770-6. [Medline].
Chaitowitz, I; Heng, R; Bell, K. Managing peripherally inserted central catheter-related venous thrombosis: How I do it. Australasian Radiology. April 2006;50(2):132-135.
Jacobs BR, Haygood M, Hingl J. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children. J Pediatr. Oct 2001;139(4):593-6. [Medline].
Skippen P, Kissoon N. Ultrasound guidance for central vascular access in the pediatric emergency department. Pediatr Emerg Care. Mar 2007;23(3):203-7. [Medline].
Cairo MS, Spooner S, Sowden L, et al. Long-term use of indwelling multipurpose silastic catheters in pediatric cancer patients treated with aggressive chemotherapy. J Clin Oncol. May 1986;4(5):784-8. [Medline].
Chiang VW, Baskin MN. Uses and complications of central venous catheters inserted in a pediatric emergency department. Pediatr Emerg Care. Aug 2000;16(4):230-2. [Medline].
Dolcourt JL, Bose CL. Percutaneous insertion of silastic central venous catheters in newborn infants. Pediatrics. Sep 1982;70(3):484-6. [Medline].
Frey AM. Pediatric peripherally inserted central catheter program report: a summary of 4,536 catheter days. J Intraven Nurs. Nov-Dec 1995;18(6):280-91. [Medline].
McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. Mar 20 2003;348(12):1123-33. [Medline].
Roberts JR, Hedges JR. Clinical Procedures in Emergency Medicine. 3rd ed. Philadelphia, PA: WB Saunders Co; 1998:295-301.
Stovroff M, Teague WG. Intravenous access in infants and children. Pediatr Clin North Am. Dec 1998;45(6):1373-93, viii. [Medline].
| Age (y) | Weight (kg) | Gauge | French | Length (cm) |
| < 1, newborn | 4-8 | 24 | 3.0 | 5-12 |
| < 1 | 5-10 | 22 | 3.0-3.5 | 5-12 |
| 1-3 | 10-15 | 20 | 4.0 | 5-15 |
| 3-8 | 15-30 | 18-20 | 4.0-5.0 | 5-25 |
| >8 | 30-70 | 16-20 | 5.0-8.0 | 5-30 |

